Abstracts (HTML) List of Authors

Obser, T

Characterization of activity and cleavage of von Willebrand disease type 2B variants

Oldenburg, J

Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Thrombophilic Phaenotype in a Family with High Frequency of Homozygous Antithrombin Deficiency Typ IIb Budapest 3 and Mild Factor VII Deficiency due to Homozygous Polymorphisms in the Factor 7 Gene and Antithrombotic Treatment
Aptamer-based ex vivo monitoring of thrombin and activated protein C generation on blood outgrowth endothelial cells for individualized assessment of the protein C pathway

Oleshko, O

von Willebrand factor (vWF) significantly modifies the sedimentation profile of FVIII-containing immune complexes (FVIII-IC) based on the type of anti-FVIII antibodies

Olive, D

Evolution of platelet phenotype during SARS-CoV-2 infection

Olivieri, M

Real-world experience on the use of rIX-FP in patients with haemophilia B: Interim results from a prospective, non-interventional, post-market surveillance study in Germany
Newly diagnosed children and adolescents with haemophilia A and B in Germany – the GEPHARD study of the `Standing Commission Paediatrics of the Society for Thrombosis and Haemostasis Research
A retrospective patient chart review of real-world clinical outcomes and prophylactic factor VIII consumption in Italian patients with haemophilia A switching to extended dosing intervals with rVIII SingleChain
A comparison of prophylaxis dosing frequency and associated clinical outcomes between rVIII-SingleChain and other rFVIII products commonly used in Italian patients with haemophilia A

Orlandi, S

Platelet Distribution Width as a marker of platelet reactivity and platelet activation status in men and women of the Moli-family cohort

Oseev, A

Assessment of primary hemostasis with an acoustic biosensor using shear dependent kinetics behavior: principle and limitations

Osswald, S

Red Cell Omega-3 FA Correlate with Reduced DDimer and Beta-Thromboglobulin as Markers of Coagulation Activation in Atrial Fibrillation

Ott, HW

A novel approach to laboratory assessment of platelet von Willebrand factor

Otto, O

Low adhesion and interaction forces of Myh9 mutant platelets lead to impaired clot retraction and unstable thrombus formation
Platelets from patients with MYH9 related disorders are mechanically stiffer

Ozelo, M

Second interim analysis results from the STASEY trial: A single-arm, multicentre, open-label, phase III clinical trial to evaluate the safety and tolerability of emicizumab prophylaxis in persons with haemophilia A (PwHA) with FVIII inhibitors